Proqr Therapeutics Eo 04 Stock Target Price
| 0PQ Stock | EUR 3.40 0.01 0.29% |
PROQR THERAPEUTICS EO 04 fundamentals help investors to digest information that contributes to PROQR THERAPEUTICS's financial success or failures. It also enables traders to predict the movement of PROQR Stock. The fundamental analysis module provides a way to measure PROQR THERAPEUTICS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PROQR THERAPEUTICS stock.
PROQR |
Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
PROQR Fundamentals
| Return On Equity | -0.75 | |||
| Return On Asset | -0.26 | |||
| Operating Margin | (16.95) % | |||
| Shares Outstanding | 71.43 M | |||
| Shares Owned By Insiders | 20.89 % | |||
| Shares Owned By Institutions | 41.47 % | |||
| Revenue | 3.93 M | |||
| Gross Profit | 2.4 M | |||
| EBITDA | (66 M) | |||
| Net Income | (46.56 M) | |||
| Cash And Equivalents | 75.84 M | |||
| Cash Per Share | 1.51 X | |||
| Total Debt | 34.28 M | |||
| Debt To Equity | 0.61 % | |||
| Current Ratio | 7.77 X | |||
| Book Value Per Share | 0.91 X | |||
| Cash Flow From Operations | (47.06 M) | |||
| Earnings Per Share | (0.92) X | |||
| Target Price | 24.96 | |||
| Number Of Employees | 181 | |||
| Beta | 0.22 | |||
| Market Capitalization | 207.46 M | |||
| Z Score | 3.6 |
About PROQR THERAPEUTICS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PROQR THERAPEUTICS EO 04's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PROQR THERAPEUTICS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PROQR THERAPEUTICS EO 04 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in PROQR Stock
PROQR THERAPEUTICS financial ratios help investors to determine whether PROQR Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PROQR with respect to the benefits of owning PROQR THERAPEUTICS security.